Efficiency Of Il-17a On Neutrophil Apoptosis And Regulatory Mechanisms In Septic Rats

Yuhui Wang,Qian Fu,Yan Kang

2019-01-01

Abstract:Objective: The aim of this study was to investigate the effects of IL-17a on neutrophil apoptosis in septic rats and its mechanisms. Methods: A total of 54 healthy adult male Wistar rats were randomly divided into 9 groups: normal control group (N), sepsis 12 hours and 24 hours group (S12 hour, S24 hour, respectively), sepsis + saline group (S12 hour+NS, S24 hour+NS, respectively), and low and high doses of recombinant IL-17 treatment 12 hours and 24 hours (S12 hour+L, S24 hour+L, S12 hour+H, S24 hour+H, respectively). Rats in the normal control group were injected with the same amount of normal saline and rats in each group were treated with intraperitoneal injections. Low and high doses of recombinant IL-17 were injected into the tail veins of each group of rats with rIL-17a 0.001 mu g and 1 mu g, while rats in each group were injected with an equal amount of normal saline. Rats were collected from the carotid artery, then the neutrophils were extracted by gradient centrifugation. Neutrophil apoptosis was detected by AnnexinV-FITC and PI double staining. Caspase 3 enzyme activity in neutrophils was detected by spectrophotography. Expression levels of Bax and Bcl-2 were detected by western blot. Changes in inflammatory factor IL-17a levels in the serum were detected by ELISA method. Results: Compared to the normal control group, neutrophil apoptosis rate was lower in the sepsis group than the control group (P<0.05). PMN apoptosis was significantly inhibited in rats of the sepsis group induced by rIL-17 tail vein injections at the same time point (P<0.05). Caspase-3 activity of 12 hours and 24 hours in the IL-17 high dose group was significantly higher than that in all other groups (P<0.05). In the IL-17 low dose group, the activity of caspase-3 in 12 hours and 24 hours was lower than that in other groups (P<0.05). Compared with levels of S-Fas in each group, in low dose IL-17 groups, either in 12 hours or 24 hours, expression levels of S-Fas were significantly higher than those in other groups (P<0.05), while in the high dose IL-17 groups, expression levels of S-Fas in 12 hours and 24 hours were lower than those in other groups (P<0.05). In addition, in high dose of IL-17 groups, levels of S-Fas in 12 hours and 24 hours were lower than those in other groups (P<0.05). In PMN of high dose of IL-17, expression of protein Bax was significantly higher than that in other groups (P<0.05) at 12 and 24 hours. Expression of BAX in low dose group of IL-17 on 12 and 24 hours was lower (P<0.05), while higher in the low dose group (P<0.05) than other groups. Conclusion: High doses of IL-17a promote activation of caspase 3 and expression of s-Fas, causing apoptosis of PMN, providing fundamental leads for the clinical treatment of sepsis.